SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-20-001125
Filing Date
2020-05-08
Accepted
2020-05-08 16:26:05
Documents
8
Period of Report
2020-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 23275
2 EX-10.1 lxrp_ex101.htm EX-10.1 193326
3 EX-10.2 lxrp_ex102.htm EX-10.2 82974
4 EX-10.3 lxrp_ex103.htm EX-10.3 115563
5 EX-10.4 lxrp_ex104.htm EX-10.4 17764
6 EX-99.1 lxrp_ex991.htm EX-99.1 9546
7 lxrp_ex991img1.jpg GRAPHIC 7503
8 lxrp_ex991img2.jpg GRAPHIC 7503
  Complete submission text file 0001640334-20-001125.txt   464726
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 20860968
SIC: 1000 Metal Mining